Article
The Effect of Blood-Derived Products on the Chondrogenic and Osteogenic Differentiation…
Stem Cells International · 2019 · Markus Neubauer, author Olga Kuten, author Christoph Stotter, author Karina Kramer, author Andrea De Luna, author Thomas Muellner, author Zsombor Lacza, author Stefan Nehrer, author Francesco De Francesco, Guest Editor
Key facts
| Title | The Effect of Blood-Derived Products on the Chondrogenic and Osteogenic Differentiation Potential of Adipose-Derived Mesenchymal Stem Cells Originated from Three Different Locations |
|---|---|
| First author | Markus Neubauer, author Olga Kuten, author Christoph Stotter, author Karina Kramer, author Andrea De Luna, author Thomas Muellner, author Zsombor Lacza, author Stefan Nehrer, author Francesco De Francesco, Guest Editor |
| Journal | Stem Cells International |
| Published | Aug 21, 2019 |
| DOI | 10.1155/2019/1358267 |
| Devices mentioned | BK030001, BK030032, BK040018, BK040066, BK050026, BK050028, BK110039, DEN000008, K011699, K011786, K012043, K014104 and 37 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, FMI, GIM and 34 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1